PVF 55_Rev_3_July_2022_Submission_Declaration_by_Investigators

PVF 01 Rev 9_September 2022 Spontaneous ADR Report Form

PVF_55_Rev_2_June_2020_Submission_Declaration_by_Investigators

PVF_76-Rev_1_May_2022_Annual_progress_reporting_form-MCAZ

PVF_82_Rev_0_May_2020_Application_for_a_Clinical_Trial_Protocol_Amendment

PVF 17 Rev 0_August 2021 Medicines Safety and Monitoring Form for COVID-19 Prophylaxis

PVF 16 Rev 0_August 2021 Medicines Safety and Monitoring Form for COVID-19 Treatment

Appendix I – LEF 18 Rev 3_June 2019 – RECORD OF BULK IMPORTATION OF UNREGISTERED MEDICINES

PVF 83 Rev 0_May 2020 Application For Additional Investigators Change Of Investigators Or Additional Clinical Trial Sites

PVF 81 Rev 0_May 2020 Declaration By Co- And Sub-Investigators For GCP Compliance (1)

PVF 80 Rev 0_May 2020 Declaration By Principal Investigator For GCP Compliance

PVF 79 Rev_0 May 2020 Joint Declaration By Sponsor And Principal Investigator Concerning Sufficient Funds To Complete Study

PVF 78 Rev 0_May 2020 Recommended Format For CVs Of Individuals Participating In Clinical Trials

PVF 30 Rev 4_August 2020 Applicants Contact Details Update Form

PVF 30 Rev 4_August 2020 Applicants Contact Details Update Form